What Key Growth Drivers Are Shaping The Congenital Heart Disease (CHD) Market Forecast Toward $6.82 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Present And Forecasted Size Of The Congenital Heart Disease (CHD) Market?
In recent times, the market size of congenital heart disease (chd) has witnessed a rapid increase. The forecast suggests an increase from $4.42 billion in 2024 to $4.85 billion in 2025, representing a compound annual growth rate (CAGR) of 9.7%. The considerable growth observed in the historic period can be accredited to the heightened frequency of risk factors like obesity and smoking, advancements in diagnostic technologies, extension of the elderly population, increased awareness campaigns, advanced reimbursement policies, and augmented investment in research and development.
Expectations are high for the congenital heart disease (chd) market to experience robust expansion in the coming years. It’s projected to reach an astounding $6.82 billion by 2029, boasting a compound annual growth rate (CAGR) of 8.9%. This predicted surge during the forecast period is tied to improved access to medical services in less developed regions, increasing innovation in cardiac imaging technologies, a rise in campaigns highlighting early detection and treatment, escalated global healthcare expenditure, and evolution in personalized medicine. Foreseen trends within this period are the incorporation of minimally invasive surgeries, growth in telemedicine for offsite patient supervision and consultations, escalating demand for individualized treatment strategies, the advent of new implantable devices demonstrating improved performance and lifespan, and the inclusion of artificial intelligence and machine learning within diagnostics and therapeutical procedures.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15545&type=smp
Which Market Dynamics Are Playing A Critical Role In The Growth Of The Congenital Heart Disease (CHD) Market?
The rise in cases of maternal diabetes is projected to fuel the growth of the congenital heart disease (CHD) market. Maternal diabetes, also known as gestational diabetes mellitus (GDM), is a type of diabetes that develops in women during pregnancy, who were not diabetic before getting pregnant. Lifestyle changes, including lack of physical activity and unhealthy eating habits, along with a general increase in obesity rates among women in their child-bearing years, cause maternal diabetes. This condition can cause congenital heart disease (CHD) in babies due to the impact of high blood sugar levels on the development of the fetal heart. The mother’s heightened glucose levels can interfere with the baby’s normal heart development, heightening the CHD risk. For example, the National Health Service, a government department based in the UK, noted in October 2023, that adverse pregnancy outcomes rose from 4.9% in 2021 to 6.6% in 2022 among women diagnosed with type 2 diabetes. Thus, the soaring cases of maternal diabetes are driving the growth of the congenital heart disease (CHD) market.
What Are The Key Segment Trends Observed In The Congenital Heart Disease (CHD) Market?
The congenital heart disease (chd)market covered in this report is segmented –
1) By Type: Heart Valve Defects; Heart Wall Defects; Blood Vessel Defects; Other Types
2) By Diagnosis: Electrocardiogram; Chest X-ray; Echocardiogram; Transesophageal Echocardiogram; Pulse Oximetry; Exercise Stress Test; Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI); Cardiac Catheterization; Other Diagnosis
3) By Treatment: Interventional Cardiology; Cardiac Surgery; Telemedicine; Medication Management; Lifestyle Modifications
4) By Age Group: Infants; Children; Adolescents; Adults
5) By Application: Hospitals And Clinics; Diagnostic Centers; Ambulatory Surgical Centers; Research And Academic Institutions
Subsegments:
1) By Heart Valve Defects: Aortic Valve Stenosis; Pulmonary Valve Stenosis; Mitral Valve Prolapse; Tricuspid Valve Defects; Valve Regurgitation
2) By Heart Wall Defects: Atrial Septal Defect (ASD); Ventricular Septal Defect (VSD); Atrioventricular Septal Defect (AVSD); Hypoplastic Left Heart Syndrome (HLHS); Tetralogy of Fallot (TOF)
3) By Blood Vessel Defects: Coarctation Of The Aorta; Patent Ductus Arteriosus (PDA); Pulmonary Artery Stenosis; Transposition Of The Great Arteries (TGA); Truncus Arteriosus
4) By Other Types: Single Ventricle Defects; Ebstein’s Anomaly; Total Anomalous Pulmonary Venous Return (TAPVR); Coronary Artery Anomalies; Pulmonary Venous Obstruction
Which Long-Term Trends Will Play A Crucial Role In The Congenital Heart Disease (CHD) Market?
Key players in the congenital heart disease industry are innovating non-surgical heart valves to enhance patient results and their quality of life. Transcatheter or non-surgical heart valves are medical devices designed to manage heart valve diseases without necessitating conventional open-heart surgery. For instance, Medtronic, a medical technology firm based in the US, relaunched its Harmony Transcatheter Pulmonary Valve (TPV) System in February 2023. This revolutionary, minimally intrusive procedure offers an alternative to traditional open heart surgery for people suffering from congenital heart disease, specifically those with inherent or surgically remedied right ventricular outflow tract (RVOT) anomalies. This first-ever FDA-approved valve for the right side offers a non-invasive solution for patients dealing with severe pulmonary valve regurgitation. Following a voluntary recall, the Harmony TPV System which originally got U.S. FDA approval in 2021 was reintroduced, attesting to Medtronic’s dedication to improving treatment options for congenital heart disease patients.
Who Are The Leading Companies Driving The Congenital Heart Disease (CHD) Market?
Major companies operating in the congenital heart disease (CHD) market are Pfizer Inc., AstraZeneca Plc, Abbott Laboratories, Novartis AG, Medtronic, Siemens Healthineers, Philips Healthcare, Roche Diagnostics International Ltd., Boston Scientific Corp., Laboratory Corporation of America Holdings (LabCorp), Terumo Corporation, Mindray Medical International Limited, Canon Medical Systems Corporation, Masimo Corporation, Neusoft Corp., Carestream Health, Midmark Corporation, Contec Medical Systems, Randox Laboratories Ltd., Schiller AG, BPL Medical Technologies, Compumedics Limited, Biocare Medical, Bionet America Inc., Nasan Medical Electronics Pvt Ltd
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/congenital-heart-disease-chd-global-market-report
Which Region Is Forecasted To Lead The Congenital Heart Disease (CHD) Market In The Coming Years?
North America was the largest region in the congenital heart disease (CHD) market in 2024. The regions covered in the congenital heart disease (CHD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=15545&type=smp
Browse Through More Reports Similar to the Global Congenital Heart Disease (CHD) Market 2025, By The Business Research Company
Cardiovascular Ultrasound Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cardiovascular-ultrasound-global-market-report
Cardiovascular Surgery Devices And Equipment Global Market Report 2025
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
